AptarGroup
- Market cap
- 7.66B
- P/E (TTM)i
- 21.74
- P/Bi
- 2.91
- EPSi
- 5.89
- Div yieldi
- 1.57%
- 52W posi
- 42%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions increased by 1 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 97.47% +0.09pp
- Institutions
- 623 +1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Top holders as of 2026-06-30
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 30 buys · 18 sells
| Name | Role | Stake |
|---|---|---|
| Stephan Tanda | Chief Executive Officer | 0.38% |
| Robert Kuhn | Chief Financial Officer | 0.11% |
| Daniel Ackerman | Chief Accounting Officer | 0.05% |
| Gael Touya | President of Aptar Pharma | 0.05% |
| Shiela Vinczeller | Chief Human Resources Officer | 0.04% |
| Mahawa Touray | -- | 0.04% |
| Ralf Wunderlich | Independent Director | 0.03% |
| Marc Prieur | President of Aptar Beauty | 0.02% |
| Hedi Tlili | President of Aptar Food + Beverage | 0.02% |
| Xiangwei Gong | President of Aptar Asia | 0.02% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-10 | Daniel Ackerman | Chief Accounting Officer | Initial Statement of Beneficial | 0 | -- |
| 2026-09-01 | Shiela Vinczeller | Chief Human Resources Officer | Open Market Disposition | -765 | $130.37 |
| 2026-08-31 | Gael Touya | President of Aptar Pharma | Other Acquisition | +2,637 | -- |
| 2026-08-31 | Gael Touya | President of Aptar Pharma | Other Derivative Acquisition | +9,531 | $130.92 |
| 2026-08-26 | Gael Touya | President of Aptar Pharma | Open Market Disposition | -3,740 | $133.69–134.55 |
| 2026-08-03 | Marc Prieur | President of Aptar Beauty | Open Market Disposition | -3,500 | $136.23–137.10 |
| 2026-08-02 | Stephan Tanda | Chief Executive Officer | Derivative Exercise and Sale | -9,838 | $74.79–136.16 |
| 2026-08-02 | Hedi Tlili | President of Aptar Food + Beverage | Open Market Disposition | -8,854 | $135.00 |
| 2026-07-15 | George Fotiades | Independent Director | Other Acquisition | +151 | -- |
| 2026-07-15 | B. Owens | Independent Director | Other Acquisition | +151 | -- |
| 2026-07-15 | Candace Matthews | Independent Chairperson | Other Acquisition | +226 | -- |
| 2026-07-15 | Ralf Wunderlich | Independent Director | Other Acquisition | +151 | -- |
| 2026-07-15 | Giovanna Kampouri Monnas | Independent Director | Other Acquisition | +151 | -- |
| 2026-07-15 | Matthew Trerotola | Independent Director | Other Acquisition | +151 | -- |
| 2026-07-15 | Isabelle Marey-Semper | Independent Director | Other Acquisition | +151 | -- |
| 2026-07-15 | Julie Xing | Independent Director | Other Acquisition | +151 | -- |
| 2026-07-15 | Sarah J. Glickman | Director | Other Acquisition | +151 | -- |
| 2026-06-14 | Aditya Gandhi | VP, Principal Accounting Officer & Chief Accounting Officer | Other Acquisition | +2,664 | -- |
| 2026-06-09 | Marc Prieur | President of Aptar Beauty | Intent to Sell (Form 144) | -5,000 | $113.00 |
| 2026-06-08 | Marc Prieur | President of Aptar Beauty | Open Market Disposition | -5,000 | $115.53–116.08 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 07:07:19 · For reference only, not investment advice and not tailored to your situation.